Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v3-FR Version v1-EN
Language French English
Date Updated 2019-02-15 2019-02-15
Drug Identification Number 02464349 02464349
Brand name ADLYXINE ADLYXINE
Common or Proper name Adlyxine Adlyxine
Company Name SANOFI-AVENTIS CANADA INC SANOFI-AVENTIS CANADA INC
Ingredients LIXISENATIDE LIXISENATIDE LIXISENATIDE LIXISENATIDE
Strength(s) 0.05MG 0.1MG 0.05MG 0.1MG
Dosage form(s) SOLUTION KIT SOLUTION KIT
Route of administration SUBCUTANEOUS SUBCUTANEOUS
Packaging size 2 2
ATC code A10BJ A10BJ
ATC description
Reason for discontinuation Business reasons Business reasons
Anticipated discontinuation date 2019-01-07 2019-01-07
Actual discontinuation date 2019-01-07 2019-01-07
Remaining supply date 2018-10-08 2018-10-08
Discontinuation status Discontinued Discontinued
Discontinuation decision reversal no no
Tier 3 Status No No
Information on remaining supply
Company comments
Health Canada comments